CANY
VIVO

Caxton Associates (New York)’s Meridian Bioscience Inc VIVO Stock Holding History

Caxton Associates (New York)’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-27,549
Closed -$715K – 768
2022
Q1 		$715K Buy
+27,549
New +$715K 0.06% 143